Objective: Although the use of complementary and alternative medicine (CAM) in children is increasing, little is known about its use in children with human immunodeficiency virus (HIV) infection. This study investigated the use of CAM by parents of children with HIV infection (H), children with asthma (A), and well children (W). Our hypothesis was that parents of the H group are more likely to use CAM than parents of the W or A group because of the nature and severity of the illness.
Materials and Methods: Parents of 152 subjects [H (n = 46), A (n = 53), and W (n = 53)] were interviewed on the use of CAM for their children, types of CAM, reasons for use/nonuse, methods of payment, and perceived benefits for their children.
Results: Compared with parents of the W and A groups, parents of the H group were less likely to be employed, were less likely to have private insurance, were less likely to have a high school or college education, and were more likely to be black. Interestingly, 38% of the W parents used CAM in their children compared with 22% in the H group and 25% in the A group. More than 80% of all three groups paid out of pocket for their use of CAM in their children. Within these groups, H parents were more likely to want CAM as part of their child’s medical care (H = 91% vs W = 75% and A = 67%, P = 0.02) and were more likely to believe that CAM was expensive (H = 78% vs W = 57% and A = 60%, P < 0.01).
Conclusions: Our study revealed a relatively high rate of CAM usage by parents of all three study groups. Although parents of children with HIV infection were more likely to want CAM as part of their children’s medical care, their rate of CAM usage was not higher than that in well children. This may be related to their socioeconomic factors. A larger and more diverse study population may provide more information on factors contributing to CAM usage in chronically ill and well children.
* Complementary and alternative medicine (CAM) usage in children with human immunodeficiency virus (HIV) infection and asthma and well children was relatively high in our pediatric patient population.
* Parents/guardians of HIV-infected children demonstrated the highest interest in CAM therapy.
* CAM usage was not higher in HIV-infected children compared with well children and children with a less severe chronic condition such as asthma.
* Level of education, employment, and ethnicity appear to influence the use of CAM.
1. Astin J. Why patients use alternative medicine, results of a national study. JAMA 1998;279:1548–1553.
2. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997. JAMA 1998;280:1569–1575.
3. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States, prevalence, costs, and patterns of use. N Engl J Med 1993;328:246–252.
4. Barnes PM, Powell-Griner E, McFann K, et al. CDC: Complementary and Alternative Medicine Use Among Adults: United States, 2002. Advance Data from Vital and Health Statistics, May 27, 2004, Number 343.
5. Krauss HH, Godfrey C, Kirk J, et al. Alternative healthcare: its use by individuals with physical disabilities. Arch Phys Med Rehabil 1998;79:1440–1447.
6. Grootenhuis MA, Last BF, de Graff-Nijkerk JH, et al. Use of alternative treatment in pediatric oncology. Cancer Nursing 1998;21:282–288.
7. Stern RC, Canda ER, Doershuk CF. Use of nonmedicinal treatment by cystic fibrosis patients. J Adolesc Health 1992;13:612–615.
8. London AS, Foote-Ardah CE, Fleishman JA, et al. Use of alternative therapists among people in care for HIV in the United States. Am J Public Health 2003;93:980–987.
9. Ernst J. Alternative treatment modalities in human immunodeficiency virus/acquired immune deficiency syndrome. Clin Infect Dis 2003;37(Suppl 2):S150–S153.
10. Shenfield G, Lim E, Allen H. Survey of the use of complementary medicines and therapies in children with asthma. J Paediatr Child Health 2002;38:252–257.
11. Sanders H, Davis MF, Duncan B, et al. Use of complementary and alternative medical therapies among children with special health care needs in southern Arizona. Pediatrics 2003;111:584–587.
12. Shen J, Andersen R, Albert PS, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complementary Altern Med 2002;2:8.
13. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999;282:531–538.
14. Anderson W, O’Connor BB, MacGregor RR, et al. Patient use and assessment of conventional and alternative therapies for HIV infection and AIDS. AIDS 1993;7:561–566.
15. Barton SE, Hawkins DA, Jadresic DM, et al. Alternative treatment for HIV infection. Br Med J1989;298:1519–1520.
16. Fairfield KM, Eisenberg DM, Davis RB, et al. Patterns of use, expenditures and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998;158:2257–2264.
17. Greenblatt RM, Hollander H, McMaster JR, et al. Polypharmacy among patients attending an AIDS clinic; utilization of prescribed, unorthodox and investigational treatments. J Acquir Immune Defic Syndr1991;4:136–143.
18. Hand R. Alternative therapies used by patients with AIDS. N Engl J Med 1989;320:629–630.
19. Ernst E. Prevalence of complementary and alternative medicine for children: a systematic review.Eur J Pediatr 1999;158:7–11.
20. Spigelblatt L, Laine-Ammara S, Pless B, et al. The use of alternative medicine by children.Pediatrics 1994;94:811–814.
21. Mottonen M, Uhari M. Use of micronutrients and alternative drugs by children with acute lymphoblastic leukemia. Med Pediatr Oncol 1997;28:205–208.
22. Fernandez C, Stutzer C, MacWilliam L, et al. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and non-use. J Clin Oncol 1998;16:1279–1286.
23. Southwood T, Malleson PN, Roberts-Thomson PJ, et al. Unconventional remedies used for patients with juvenile arthritis. Pediatrics 1990;85:150–154.
24. Loman DG. The use of complementary and alternative health care practices among children. J Pediatr Health Care 2003;17:58–63.
25. American Academy of Pediatrics. Human Immunodeficiency Virus. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, American Academy of Pediatrics, 2003, pp. 362–364.
26. National Center for Complementary and Alternative Medicine. Get the Facts. What Is Complementary and Alternative Medicine (CAM)? NCCAM Publication No. D156, May 2002.
27. Ostrow M, Cornelisse PGA, Health KV, et al. Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:115–120.
28. Nokes K, Kendrew J, Longo M. Alternative/complementary therapies used by persons with HIV disease. J Assoc Nurses AIDs Care 1995;6:19–24.
29. Singh N, Squier C, Sivek C, et al. Determinants of nontraditional therapy use in patients with HIV infection, a prospective study. Arch Intern Med 1996;156:197–201.
30. Bridevaux IP. A survey of patients’ out-of-pocket payments for complementary and alternative medicine therapies. Complement Ther Med 2004;12:48–50.
31. Cleary-Guida MB, Okvat HA, Oz MC, et al. A regional survey of health insurance coverage for complementary and alternative medicine: current status and future ramifications. J Altern Complement Med 2001;7:269–273.
32. Kassler W, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991;151:2281–2288.
33. Fernandez C, Stutzer C. Alternative therapies in childhood cancer. N Engl J Med 1999;340:569–570.
34. Angell M, Kassirer J. Alternative medicine: the risks of untested and unregulated remedies. N Engl J Med 1998;339:839–841.